ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Although tyrosine-kinase activity of BCR/ABL is essential for CML pathogenesis, additional BCR/ABL functions along with hematopoietic stem/progenitor cells and tumour microenvironment biology are likely to contribute to the disease development and maintenance.